Biogen (BIIB) Non Operating Income (2014 - 2022)

Biogen has reported Non Operating Income for 9 years, with the latest figure at -$263.3 million in Q1 2022.

• On a quarterly basis, Non Operating Income rose 48.06% year-over-year to -$263.3 million in Q1 2022; TTM through Mar 2022 was -$851.9 million, a 867.48% decrease from a year earlier, with the FY2025 full-year figure at -$305.6 million, up 11.06% from the prior year.
• Non Operating Income was -$263.3 million for Q1 2022 at Biogen, down from -$182.1 million in the prior quarter.
• The five-year high for Non Operating Income was $683.5 million in Q4 2020, with the low at -$506.9 million in Q1 2021.
• Average Non Operating Income over 5 years is -$45.1 million, with a median of -$41.0 million recorded in 2018.
• The sharpest annual moves came in 2019 and 2020: Non Operating Income slumped 472.17% in 2019, then jumped 1486.41% in 2020.
• Over 5 years, Non Operating Income stood at -$28.6 million in 2018, then sank by 72.38% to -$49.3 million in 2019, then surged by 1486.41% to $683.5 million in 2020, then sank by 126.64% to -$182.1 million in 2021, then slumped by 44.59% to -$263.3 million in 2022.
• The last three Non Operating Income figures came in at -$263.3 million (Q1 2022), -$182.1 million (Q4 2021), and -$502.9 million (Q3 2021), per Business Quant data.